News about Digitalization

Brenig Therapeutics to Present Hybrid AI Drug Discovery Platform at Keystone Symposia Computational Advances in Drug Discovery

Brenig Therapeutics will showcase its hybrid AI drug discovery platform at the Keystone Symposia, with Dr. Alexei Pushechnikov highlighting its collaboration with Expert Systems, Inc.

Digitalization | 05/05/2026 | By News Bureau

Worldwide Clinical Trials Medidata Expand Partnership to Power AI-Driven Clinical Trials

The collaboration between Worldwide Clinical Trials and Medidata integrates Medidata’s AI platform and virtual assistant Dot to enable faster, more connected and data-driven clinical research across global trial operations.

Digitalization | 27/04/2026 | By News Bureau |  170

Trinity Launches InsightsEDGE Digital Twins

Trinity launches InsightsEDGE Digital Twins, using generative AI to turn decades of expertise into real-time, data-driven insights that help life sciences teams anticipate market shifts and optimise commercial decisions.

Digitalization | 13/04/2026 | By News Bureau |  126

AI-Driven Drug Discovery Workshop Held at CSIR-HRDC Ghaziabad

A three-day AI-driven drug discovery workshop at CSIR-HRDC Ghaziabad equipped CSIR scientists and technical officers with advanced tools, techniques, and applications in modern pharmaceutical research.

Digitalization | 10/04/2026 | By News Bureau |  123

UK MHRA Secures EUro 3.6 Million to Expand AI Airlock for Safer Medical AI Innovation

Backed by multi-year government funding, the UK’s first AI medical device regulatory sandbox will scale real-world testing, strengthen oversight and accelerate safe adoption of clinical AI technologies.

Digitalization | 09/04/2026 | By News Bureau |  231

Transgene, NEC Bio B.V. Sign Licensing Deal to Advance AI-Driven Cancer Vaccine

Transgene's Agreement wirh NEC Bio B.V. to accelerate development of TG4050, a personalised neoantigen immunotherapy for head and neck cancer, combining viral vector technology with AI-based prediction.

Digitalization | 07/04/2026 | By News Bureau |  101

Eli Lilly Eyes USD 2 Billion AI Drug Discovery Deal with Insilico Medicine

Eli Lilly is set to enter into a deal worth over USD 2 billion with Hong Kong-based Insilico Medicine to accelerate drug discovery using artificial intelligence, signaling a major push toward AI-driven pharmaceutical innovation.

Digitalization | 30/03/2026 | By Darshana |  164

Discovery Life Sciences and Mindpeak Partner for AI Cancer Biomarker Testing

Discovery Life Sciences and Mindpeak partner to bring AI-driven cancer biomarker testing in global clinical trials, aiming to reduce variability in biomarker interpretation and improve accuracy in drug development.

Digitalization | 25/03/2026 | By News Bureau |  106

Insilico Medicine Launches PandaClaw AI Platform for Drug Discovery

Insilico Medicine launches PandaClaw AI platform to accelerate drug discovery, enabling real-time analysis, target identification and disease hypothesis generation through an intuitive natural language interface.

Digitalization | 24/03/2026 | By News Bureau |  131

Earendil Labs Raises USD 787 Million to Scale AI-Driven Biologics Discovery

Earendil Labs will use its USD 787 million financing to scale its Artificial Intelligence (AI)-driven R&D platform, expand inter-disciplinary teams and advance a pipeline of antibody and biologics programmes targeting serious diseases.

Digitalization | 21/03/2026 | By News Bureau |  270